
Targeted mRNA Therapy Halts Autoimmune Progression in Broad Multi-Center Trials
In an illustrative late-stage trial scenario, a targeted mRNA therapy halts autoimmune progression across 18 hospitals. This is not medical news; we explain how such trials work.
Mina Takahashi • • 3 min read


